Was 4-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?

被引：14
|
作者：
Neuhoff, Sibylle [1 ]
Tucker, Geoffrey T. [2 ]
机构：
[1] Simcyp Certara Ltd, Sheffield, S Yorkshire, England
[2] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2018年 / 84卷 / 07期
关键词：
4-hydroxycholesterol; biomarker; CYP3A4; CONCISE GUIDE; 4-BETA-HYDROXYCHOLESTEROL; METABOLISM; RIFAMPICIN;
D O I：
10.1111/bcp.13538
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1620 / 1621
页数：2
相关论文
共 50 条
  • [21] Expression of CYP3A4 mRNA is correlated with CYP3A4 protein level and metabolic activity in human liver
    Watanabe, M
    Kumai, T
    Matsumoto, N
    Tanaka, M
    Suzuki, S
    Satoh, T
    Kobayashi, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 (04) : 459 - 462
  • [22] Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity
    Westlind-Johnsson, A
    Hermann, R
    Huennemeyer, A
    Hauns, B
    Lahu, G
    Nassr, N
    Zech, K
    Ingelman-Sundberg, M
    von Richter, O
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (04) : 339 - 349
  • [23] 480 Activity of Cyp3A in Mothers and Their Newborns Using 4B-Hydroxycholesterol as a Marker
    K Wide
    S Ekmark-Sergel
    H Nylen
    U Diczfalusy
    L Bertilsson
    Pediatric Research, 2010, 68 : 245 - 245
  • [24] Effect of influenza immunization on CYP3A4 activity
    Hayney, MS
    Hammes, RJ
    Fine, JP
    Bianco, JA
    VACCINE, 2001, 20 (5-6) : 858 - 861
  • [25] Effect of NIPRISANA® on CYP3A4 activity in vitro
    Adzu, Bulus
    Masimirembwa, Collen
    Mustapha, Kudirat Bola
    Thelingwani, Roslyn
    Kirim, Rukaiyatu Abdullahi
    Gamaniel, Karniyus Shingu
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2015, 40 (01) : 115 - 118
  • [26] Effects of metronidazole on hepatic CYP3A4 activity
    Haas, CE
    Kaufman, DC
    DiCenzo, RC
    PHARMACOTHERAPY, 2001, 21 (10): : 1192 - 1195
  • [27] Characterization of the modulation of the CYP3A4 activity by Efavirenz
    Hariparsad, N
    Nallani, SC
    Desai, PB
    DRUG METABOLISM REVIEWS, 2003, 35 : 79 - 79
  • [28] Cytochrome P450 Induction by Rifampicin in Healthy Subjects: Determination Using the Karolinska Cocktail and the Endogenous CYP3A4 Marker 4β-Hydroxycholesterol
    Kanebratt, K. P.
    Diczfalusy, U.
    Backstrom, T.
    Sparve, E.
    Bredberg, E.
    Bottiger, Y.
    Andersson, T. B.
    Bertilsson, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (05) : 589 - 594
  • [29] Genetic epidemiology of induced CYP3A4 activity
    Rahmioglu, Nilufer
    Heaton, James
    Clement, Gail
    Gill, Raj
    Surdulescu, Gabriela
    Zlobecka, Karolina
    Hodgkiss, Dylan
    Ma, Yongmin
    Hider, Robert C.
    Smith, Norman W.
    Ahmadi, Kourosh R.
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (10): : 642 - 651
  • [30] Effect of NIPRISAN® on CYP3A4 activity in vitro
    Bulus Adzu
    Collen Masimirembwa
    Kudirat Bola Mustapha
    Roslyn Thelingwani
    Rukaiyatu Abdullahi Kirim
    Karniyus Shingu Gamaniel
    European Journal of Drug Metabolism and Pharmacokinetics, 2015, 40 : 115 - 118
12345